Aclaris Therapeutics Inc (ACRS) earnings · rev $7.8M
These earnings events as JSON? API free 100/dayAclaris Therapeutics Inc (ACRS) is a biotechnology company listed on NASDAQ.
This ACRS earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported ACRS revenue for 2025-12-31 was $7.8M. Net income was -$64.9M. Revenue was down 58.2% from 2024-12-31 to 2025-12-31. ACRS currently screens at market cap $615.9M.
When the next ACRS 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
The change that matters: Revenue was down 58.2% from 2024-12-31 to 2025-12-31. An earnings headline that ignores that move is noise.
Not investment advice. Full ACRS research stays on the stock page; the tape stays on the quote page.
ACRS earnings FAQ
What are ACRS's latest revenue and net income?
Latest cached Aclaris Therapeutics Inc (ACRS) revenue for Dec 31, 2025 was $7.8M. Net income was -$64.9M. Statements: https://lician.com/financials/acrs
What is ACRS's latest diluted EPS?
Latest cached Aclaris Therapeutics Inc (ACRS) diluted EPS for Dec 31, 2025 was -$0.53.
What period does the latest ACRS earnings print cover?
The latest cached Aclaris Therapeutics Inc (ACRS) earnings print covers Dec 31, 2025. The prior cached period on this page is Dec 31, 2024.
How did ACRS revenue change from the prior cached period?
Cached Aclaris Therapeutics Inc (ACRS) revenue was down 58.2% from $18.7M (Dec 31, 2024) to $7.8M (Dec 31, 2025). Statements: https://lician.com/financials/acrs
Where are ACRS earnings listed?
Cached earnings facts for Aclaris Therapeutics Inc (ACRS) are listed at https://lician.com/earnings/acrs. Statements: https://lician.com/financials/acrs
Not investment advice.